secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cogent Biosciences, Inc. (COGT)
CIK:        0001622229
Form:       8-K
Filed at:   2026-06-11T20:15:05+00:00
Accession:  0001193125-26-267566
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cogent shareholders elect three directors, ratify auditor, approve say-on-pay at 2026 annual meeting
--------------------------------------------------------------------------------

- Director nominees elected: Chris Cain (124.4M votes for), Arlene Morris (120.2M for), Todd Shegog (124.1M for).
- Ratification of PwC as independent auditor: 154.0M for, 399K against, 33.6K abstentions.
- Advisory vote on executive compensation approved: 129.2M for, 13.98M against, 32.6K abstentions.
- Meeting held June 9, 2026; record date April 13, 2026 with 170.8M shares entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622229/000119312526267566/0001193125-26-267566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622229/000119312526267566/d100263d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-267566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer